A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvement. [electronic resource]
Producer: 20190826Description: 877-885 p. digitalISSN:- 1432-0843
- Administration, Oral
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bevacizumab -- administration & dosage
- Capecitabine -- administration & dosage
- Female
- Hepatic Artery
- Humans
- Infusions, Intra-Arterial
- Injections, Intravenous
- Liver Neoplasms -- drug therapy
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Invasiveness
- Oxaliplatin -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.